MELANOMA STAGE III

Clinical trials for MELANOMA STAGE III explained in plain language.

Never miss a new study

Get alerted when new MELANOMA STAGE III trials appear

Sign up with your email to follow new studies for MELANOMA STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 8 Completed 2

New combo aims to shrink melanoma tumors before surgery

Disease control Not yet recruiting

This study tests whether adding an experimental drug (PRTX007) to an approved immunotherapy (pembrolizumab) before surgery can improve outcomes for people with stage III melanoma. About 48 adults with resectable melanoma will receive the combination orally and intravenously, then…

Matched conditions: MELANOMA STAGE III

Phase: PHASE2 • Sponsor: Primmune Therapeutics, Inc. • Aim: Disease control

Last updated May 12, 2026 13:39 UTC

MELANOMA STAGE III

Get alerted when new MELANOMA STAGE III trials appear

New combo aims to shrink melanoma tumors before surgery